<?xml version="1.0" encoding="UTF-8"?><rss version="2.0" xmlns:content="http://purl.org/rss/1.0/modules/content/"><channel><title>医药魔方Pro | wechat-feeds</title><link>http://MzU1MTk1NTUwMA.favicon.privacyhide.com/favicon.ico</link><description>聚焦生物医药前沿，洞察研发投资风向</description><managingEditor> (hellodword)</managingEditor><pubDate>Fri, 26 Feb 2021 21:05:01 +0800</pubDate><image><url>http://MzU1MTk1NTUwMA.favicon.privacyhide.com/favicon.ico</url><title>医药魔方Pro | wechat-feeds</title><link>http://MzU1MTk1NTUwMA.favicon.privacyhide.com/favicon.ico</link><width>64</width><height>64</height></image><item><title>癌症免疫治疗“老兵”IL-2：研发回潮，能否续写PD-1神话？</title><link>https://mp.weixin.qq.com/s/9bPQKdj8ePjP8d_x-ahmGw</link><description></description><content:encoded><![CDATA[癌症免疫治疗“老兵”IL-2：研发回潮，能否续写PD-1神话？]]></content:encoded><pubDate>Fri, 26 Feb 2021 21:01:14 +0800</pubDate></item><item><title>诺华、BMS、吉利德都来了！oRNA疗法“来势汹汹”，新贵公司A轮融资8000万美元</title><link>https://mp.weixin.qq.com/s/UnJ5d8WOXxVm8Le2yr5EPA</link><description></description><content:encoded><![CDATA[诺华、BMS、吉利德都来了！oRNA疗法“来势汹汹”，新贵公司A轮融资8000万美元]]></content:encoded><pubDate>Thu, 25 Feb 2021 21:00:56 +0800</pubDate></item><item><title>消灭天花，消灭牛瘟！Nature重磅回顾：20项疫苗发展里程碑</title><link>https://mp.weixin.qq.com/s/iMEYX41ZYDduGUMaT3122g</link><description></description><content:encoded><![CDATA[消灭天花，消灭牛瘟！Nature重磅回顾：20项疫苗发展里程碑]]></content:encoded><pubDate>Wed, 24 Feb 2021 21:08:30 +0800</pubDate></item><item><title>Cell里程碑：治疗脑瘤，PD-1 不行，这个靶点有戏！</title><link>https://mp.weixin.qq.com/s/NjaNFF9gzp-wTe-XdNTdAA</link><description></description><content:encoded><![CDATA[Cell里程碑：治疗脑瘤，PD-1 不行，这个靶点有戏！]]></content:encoded><pubDate>Tue, 23 Feb 2021 21:04:59 +0800</pubDate></item><item><title>Nature：科学家为PD-1抗体找到了新搭档，联合治疗使37.5%的小鼠肿瘤完全消退</title><link>https://mp.weixin.qq.com/s/EBNh6qa9Ks6o3nN8y8fNVw</link><description></description><content:encoded><![CDATA[Nature：科学家为PD-1抗体找到了新搭档，联合治疗使37.5%的小鼠肿瘤完全消退]]></content:encoded><pubDate>Mon, 22 Feb 2021 21:01:13 +0800</pubDate></item><item><title>新抗原疫苗临床开发火热，PD-1抗体是有力搭档 | Nature最新报告</title><link>https://mp.weixin.qq.com/s/UC-tkeHbQHePsDPEdNvRpQ</link><description></description><content:encoded><![CDATA[新抗原疫苗临床开发火热，PD-1抗体是有力搭档 | Nature最新报告]]></content:encoded><pubDate>Sun, 21 Feb 2021 20:59:41 +0800</pubDate></item><item><title>默沙东、辉瑞、拜耳等巨头争相布局！生物分子凝聚体，或成药物研发下一个风口</title><link>https://mp.weixin.qq.com/s/mZPsOOuRSrgK8_-4zWu9ug</link><description></description><content:encoded><![CDATA[默沙东、辉瑞、拜耳等巨头争相布局！生物分子凝聚体，或成药物研发下一个风口]]></content:encoded><pubDate>Sat, 20 Feb 2021 21:00:49 +0800</pubDate></item><item><title>挑战肝癌，新款ADC药物来了！</title><link>https://mp.weixin.qq.com/s/jxtkuUeAq6ppUT_WimIoLA</link><description></description><content:encoded><![CDATA[挑战肝癌，新款ADC药物来了！]]></content:encoded><pubDate>Fri, 19 Feb 2021 20:59:42 +0800</pubDate></item><item><title>首个人体试验II期临床结果公布！粪菌移植成功逆转癌症患者对PD-1抗体的应答 | Science</title><link>https://mp.weixin.qq.com/s/5oUhd_WKUluvYq2dXwOI9Q</link><description></description><content:encoded><![CDATA[首个人体试验II期临床结果公布！粪菌移植成功逆转癌症患者对PD-1抗体的应答 | Science]]></content:encoded><pubDate>Thu, 18 Feb 2021 20:58:27 +0800</pubDate></item><item><title>胰腺癌是如何形成的？Nature揭秘：KRAS突变和组织损伤，缺一不可！</title><link>https://mp.weixin.qq.com/s/b5SLajt4Y6KVdX_n0-bj_g</link><description></description><content:encoded><![CDATA[胰腺癌是如何形成的？Nature揭秘：KRAS突变和组织损伤，缺一不可！]]></content:encoded><pubDate>Wed, 17 Feb 2021 20:58:27 +0800</pubDate></item></channel></rss>